130 related articles for article (PubMed ID: 28456375)
21. Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model.
Tasaki Y; Yamamoto J; Omura T; Sakaguchi T; Kimura N; Ohtaki K; Ono T; Suno M; Asari M; Ohkubo T; Noda T; Awaya T; Shimizu K; Matsubara K
Neurosci Lett; 2012 Jul; 521(1):15-9. PubMed ID: 22617635
[TBL] [Abstract][Full Text] [Related]
22. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.
Shepherd KR; Lee ES; Schmued L; Jiao Y; Ali SF; Oriaku ET; Lamango NS; Soliman KF; Charlton CG
Pharmacol Biochem Behav; 2006 Mar; 83(3):349-59. PubMed ID: 16580056
[TBL] [Abstract][Full Text] [Related]
23. The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson's disease.
Schwenkgrub J; Zaremba M; Joniec-Maciejak I; Cudna A; Mirowska-Guzel D; Kurkowska-Jastrzębska I
PLoS One; 2017; 12(7):e0182019. PubMed ID: 28753652
[TBL] [Abstract][Full Text] [Related]
24. Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.
Vucković MG; Wood RI; Holschneider DP; Abernathy A; Togasaki DM; Smith A; Petzinger GM; Jakowec MW
Neurobiol Dis; 2008 Nov; 32(2):319-27. PubMed ID: 18718537
[TBL] [Abstract][Full Text] [Related]
25. Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein.
Nakagawa S; Kim JE; Lee R; Malberg JE; Chen J; Steffen C; Zhang YJ; Nestler EJ; Duman RS
J Neurosci; 2002 May; 22(9):3673-82. PubMed ID: 11978843
[TBL] [Abstract][Full Text] [Related]
26. Trx-1 ameliorates learning and memory deficits in MPTP-induced Parkinson's disease model in mice.
Zhang X; Bai L; Zhang S; Zhou X; Li Y; Bai J
Free Radic Biol Med; 2018 Aug; 124():380-387. PubMed ID: 29960099
[TBL] [Abstract][Full Text] [Related]
27. The phosphodiesterase inhibitor rolipram promotes survival of newborn hippocampal neurons after ischemia.
Sasaki T; Kitagawa K; Omura-Matsuoka E; Todo K; Terasaki Y; Sugiura S; Hatazawa J; Yagita Y; Hori M
Stroke; 2007 May; 38(5):1597-605. PubMed ID: 17379823
[TBL] [Abstract][Full Text] [Related]
28. Activation of cAMP signaling facilitates the morphological maturation of newborn neurons in adult hippocampus.
Fujioka T; Fujioka A; Duman RS
J Neurosci; 2004 Jan; 24(2):319-28. PubMed ID: 14724230
[TBL] [Abstract][Full Text] [Related]
29. Cilostazol improves hippocampus-dependent long-term memory in mice.
Yanai S; Semba Y; Ito H; Endo S
Psychopharmacology (Berl); 2014 Jul; 231(13):2681-93. PubMed ID: 24464529
[TBL] [Abstract][Full Text] [Related]
30. (1)H NMR-based metabolomics study on a goldfish model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Lu Z; Wang J; Li M; Liu Q; Wei D; Yang M; Kong L
Chem Biol Interact; 2014 Nov; 223():18-26. PubMed ID: 25242684
[TBL] [Abstract][Full Text] [Related]
31. Oral Administration of Probiotic
Ishii T; Furuoka H; Kaya M; Kuhara T
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33567772
[TBL] [Abstract][Full Text] [Related]
32. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid-induced Parkinson's disease in mice.
Shi X; Chen YH; Liu H; Qu HD
Mol Med Rep; 2016 Sep; 14(3):2397-404. PubMed ID: 27484986
[TBL] [Abstract][Full Text] [Related]
35. Simvastatin Improves Behavioral Disorders and Hippocampal Inflammatory Reaction by NMDA-Mediated Anti-inflammatory Function in MPTP-Treated Mice.
Yan J; Liu A; Fan H; Qiao L; Wu J; Shen M; Lai X; Huang J
Cell Mol Neurobiol; 2020 Oct; 40(7):1155-1164. PubMed ID: 32016638
[TBL] [Abstract][Full Text] [Related]
36. Social odor recognition: a novel behavioral model for cognitive dysfunction in Parkinson's disease.
Monaghan MM; Leddy L; Sung ML; Albinson K; Kubek K; Pangalos MN; Reinhart PH; Zaleska MM; Comery TA
Neurodegener Dis; 2010; 7(1-3):153-9. PubMed ID: 20197696
[TBL] [Abstract][Full Text] [Related]
37. Rolipram-induced improvement of cognitive function correlates with changes in hippocampal CREB phosphorylation, BDNF and Arc protein levels.
Zhong Y; Zhu Y; He T; Li W; Yan H; Miao Y
Neurosci Lett; 2016 Jan; 610():171-6. PubMed ID: 26552011
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model.
Yang W; Chen YH; Liu H; Qu HD
Int J Mol Med; 2015 Nov; 36(5):1369-76. PubMed ID: 26648012
[TBL] [Abstract][Full Text] [Related]
39. Neurochemical findings in the MPTP model of Parkinson's disease.
Schmidt N; Ferger B
J Neural Transm (Vienna); 2001; 108(11):1263-82. PubMed ID: 11768626
[TBL] [Abstract][Full Text] [Related]
40. Geraniol attenuates α-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent manner.
Rekha KR; Selvakumar GP; Santha K; Inmozhi Sivakamasundari R
Biochem Biophys Res Commun; 2013 Nov; 440(4):664-70. PubMed ID: 24103762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]